The cell immunotherapy sector is partially active, with Sanyuan Gene rising over 12%
The cell immunotherapy sector is somewhat active, with Sanyuan Gene rising over 12%. YKYY, Sun-Novo, JOINN, RemeGen, HITECK, and others are also following suit
688658
13.013.13%